BRIEF published on 11/22/2024 at 15:20, 1 year 5 months ago Xenetic Biosciences partage ses connaissances sur l'efficacité de la DNase I dans le traitement du cancer Traitement Du Cancer Biosciences Xénétiques Données Précliniques ADNase I Blocage Du Point De Contrôle Immunitaire
BRIEF published on 11/22/2024 at 14:51, 1 year 5 months ago Vanguard Group Discloses Position in International Paper Company Form 8.3 Takeover Code Vanguard Group Stock Disclosure International Paper
BRIEF published on 11/22/2024 at 14:51, 1 year 5 months ago Le groupe Vanguard révèle sa position dans une société papetière internationale Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Divulgation Des Stocks Document International
BRIEF published on 11/22/2024 at 14:50, 1 year 5 months ago The Vanguard Group Discloses Significant Interest in Centamin plc Takeover Code Securities Disclosure Vanguard Group Mining Sector Centamin Plc
BRIEF published on 11/22/2024 at 14:50, 1 year 5 months ago Le groupe Vanguard révèle une participation significative dans Centamin plc Groupe Vanguard Code De Prise De Contrôle Secteur Minier Divulgation Des Valeurs Mobilières Centamine Plc
BRIEF published on 11/22/2024 at 14:50, 1 year 5 months ago Jaguar Health Seeks Partner for Dog Diarrhea Drug NP300 FDA Approval Jaguar Health NP300 Dog Diarrhea Pet Connect Conference
BRIEF published on 11/22/2024 at 14:50, 1 year 5 months ago Jaguar Health recherche un partenaire pour le médicament NP300 contre la diarrhée canine Approbation De La FDA Santé Jaguar NP300 Diarrhée Du Chien Conférence Pet Connect
BRIEF published on 11/22/2024 at 14:49, 1 year 5 months ago The Vanguard Group Discloses Position in AngloGold Ashanti Takeover Code Securities Disclosure Vanguard Group AngloGold Ashanti Share Dealings
BRIEF published on 11/22/2024 at 14:49, 1 year 5 months ago Le groupe Vanguard révèle sa position dans AngloGold Ashanti Groupe Vanguard Code De Prise De Contrôle AngloGold Ashanti Divulgation Des Valeurs Mobilières Négociations D'actions
BRIEF published on 11/22/2024 at 14:48, 1 year 5 months ago The Vanguard Group Discloses Stake in International Distribution Services plc Securities Takeover Code Vanguard Group International Distribution Stake Disclosure
Published on 04/23/2026 at 15:00, 1 hour 18 minutes ago critical elements annonce les résultats de l'assemblée annuelle des actionnaires
Published on 04/23/2026 at 15:00, 1 hour 18 minutes ago Critical Elements Announces the Results from The Annual Meeting of Shareholders
Published on 04/23/2026 at 14:30, 1 hour 48 minutes ago Klondike Gold Engages Fundamental Research Corp. for Analyst Coverage
Published on 04/23/2026 at 14:30, 1 hour 48 minutes ago Hillcrest Energy Technologies Finalizes A-Sample Design of ZVS PCS1000 Sidecar Power Unit for Next-Generation AI Data Centers
Published on 04/23/2026 at 14:00, 2 hours 18 minutes ago Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
Published on 04/23/2026 at 16:06, 11 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 04/23/2026 at 16:05, 12 minutes ago Brandwatch Expands APAC Data Coverage to Strengthen Global Insight for Marketers
Published on 04/23/2026 at 16:04, 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Published on 04/23/2026 at 15:39, 38 minutes ago DECLARATION DU NOMBRE D’ACTIONS ET DE DROITS DE VOTE
Published on 04/23/2026 at 15:00, 1 hour 18 minutes ago STEF : Descriptif du programme de rachat d'actions
Published on 04/23/2026 at 14:30, 1 hour 48 minutes ago KURMA PARTNERS, AN EURAZEO GROUP COMPANY, CLOSES €215 MILLION BIOFUND IV
Published on 04/23/2026 at 14:30, 1 hour 48 minutes ago KURMA PARTNERS, MEMBRE DU GROUPE EURAZEO, ANNONCE LE CLOSING FINAL DE SON NOUVEAU FONDS BIOFUND IV A 215 MILLIONS D’EUROS
